123 related articles for article (PubMed ID: 9918796)
1. Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells.
Tomiyasu K; Satoh E; Oda Y; Nishizaki K; Kondo M; Imanishi J; Mazda O
Biochem Biophys Res Commun; 1998 Dec; 253(3):733-8. PubMed ID: 9918796
[TBL] [Abstract][Full Text] [Related]
2. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
[TBL] [Abstract][Full Text] [Related]
3. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
4. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
5. Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells.
Mizuguchi H; Hosono T; Hayakawa T
FEBS Lett; 2000 Apr; 472(2-3):173-8. PubMed ID: 10788606
[TBL] [Abstract][Full Text] [Related]
6. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.
Mazda O
Curr Gene Ther; 2002 Sep; 2(3):379-92. PubMed ID: 12189722
[TBL] [Abstract][Full Text] [Related]
7. Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.
Haan KM; Aiyar A; Longnecker R
J Virol; 2001 Mar; 75(6):3016-20. PubMed ID: 11222728
[TBL] [Abstract][Full Text] [Related]
8. Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.
Belt PB; Groeneveld H; Teubel WJ; van de Putte P; Backendorf C
Gene; 1989 Dec; 84(2):407-17. PubMed ID: 2482230
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
[TBL] [Abstract][Full Text] [Related]
10. [Progress of EBNA1/oriP-based plasmid applied in gene therapy].
He J; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):507-10. PubMed ID: 16108385
[TBL] [Abstract][Full Text] [Related]
11. The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.
Giannakopoulos A; Stavrou EF; Zarkadis I; Zoumbos N; Thrasher AJ; Athanassiadou A
J Mol Biol; 2009 Apr; 387(5):1239-49. PubMed ID: 19248788
[TBL] [Abstract][Full Text] [Related]
12. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo.
Tu G; Kirchmaier AL; Liggitt D; Liu Y; Liu S; Yu WH; Heath TD; Thor A; Debs RJ
J Biol Chem; 2000 Sep; 275(39):30408-16. PubMed ID: 10856307
[TBL] [Abstract][Full Text] [Related]
13. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.
Längle-Rouault F; Patzel V; Benavente A; Taillez M; Silvestre N; Bompard A; Sczakiel G; Jacobs E; Rittner K
J Virol; 1998 Jul; 72(7):6181-5. PubMed ID: 9621086
[TBL] [Abstract][Full Text] [Related]
14. Simian virus 40 (SV40) large T antigen-dependent amplification of an Epstein-Barr virus-SV40 hybrid shuttle vector integrated into the human HeLa cell genome.
Stary A; Sarasin A
J Gen Virol; 1992 Jul; 73 ( Pt 7)():1679-85. PubMed ID: 1321208
[TBL] [Abstract][Full Text] [Related]
15. Prolonged gene expression in primary porcine pancreatic cells using an Epstein-Barr virus-based episomal vector.
Min KA; Oh ST; Yoon KH; Kim CK; Lee SK
Biochem Biophys Res Commun; 2003 May; 305(1):108-15. PubMed ID: 12732203
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G
Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of Epstein-Barr virus-derived episomal vectors in the murine Sp2/0 myeloma cell line is dependent upon exogenous expression of human EBP2.
Habel ME; Drouin M; Jung D
Biochem Cell Biol; 2004 Jun; 82(3):375-80. PubMed ID: 15181471
[TBL] [Abstract][Full Text] [Related]
18. Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome.
Satoh E; Osawa M; Tomiyasu K; Hirai H; Shimazaki C; Oda Y; Nakagawa M; Kondo M; Kinoshita S; Mazda O; Imanishi J
Biochem Biophys Res Commun; 1997 Sep; 238(3):795-9. PubMed ID: 9325170
[TBL] [Abstract][Full Text] [Related]
19. Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors.
Mazda O; Satoh E; Yasutomi K; Imanishi J
J Immunol Methods; 1997 May; 204(2):143-51. PubMed ID: 9212831
[TBL] [Abstract][Full Text] [Related]
20. The use of Epstein-Barr virus-based shuttle vectors in rat PC12 cells.
Lindenboim L; Anderson D; Stein R
Cell Mol Neurobiol; 1997 Feb; 17(1):119-27. PubMed ID: 9118203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
